Lauras Labs derives 40% of its revenue from antiretroviral (ARV) drugs, which remain insulated from US tariffs.

Divi’s Laboratories, Piramal Pharma, Wockhardt, Cipla, Laurus Labs, Aurobindo Pharma, Glenmark Pharmaceuticals, Dr Reddy’s ...

Macquarie wrote in its note that the prohibitions outlined in the Biosecure Act will take effect with respect to these ...

On October 1, Nifty Pharma index closed 1.3% higher at 21,733 after falling for seven straight sessions amid steep tariffs by ...

The Act prohibits federal agencies from procuring/contracting with/using biotech equipment or services from companies of concern originating from China ...

The Indian stock market benchmark indices Sensex and Nifty 50 saw a sharp rebound on Monday after crashing nearly 5% last week. The Nifty 50 index tested its long-term 200-day EMA (Exponential Moving ...

Stay updated with the latest stock market news and live updates. Get real-time insights on Sensex Today, Nifty Live, stock market today, IPO news and more on Business Standard.

The pharma stocks are experiencing surge share prices in trade on October 9, 2025 after the White House reportedly mulls over the possibility of not imposing tariffs on generic medicines.